Predictors of Pharmacotherapy and Quality of Life Among Patients With Diabetic Foot Syndrome: A Cross-Sectional Study from a Tertiary Care Hospital in India
E. Pasangha1★, B. George2, K. B. Bhuvana3, D. Padmini3★ Corresponding author
- 1St. John’s Medical College, Sarjapur Road, Bangalore, Karnataka, India.
- 2Department of Endocrinology, St. Johns Medical College, Sarjapur Road, Bangalore, Karnataka, India.
- 3Department of Pharmacology, St. Johns Medical College, Sarjapur Road, Bangalore, Karnataka, India.
CORRESPONDENCE
E. Pasangha
Padmini Devi,Department of Pharmacology, St. John’s Medical College, Sarjapur Road, Beside Bank of Baroda, John Nagar, Koramangala, Bangalore, Karnataka 560034, India.
Received: 20-12-2021; Revised: 04-02-2022; Accepted: 12-02-2022.
Volume 13, Issue 1 · pp. 66–71 · PUBLISHED 2022 · DOI: 10.1177/0976500X221080291
View on J Pharmacol. Pharmacother. original site ↗
ABSTRACT
Objective: To assess the patterns and predictors of pharmacotherapy and QOL in DFS patients in an Indian tertiary care hospital. Methods: A cross-sectional study was conducted among inpatients with DFS. Data on sociodemographic and clinical factors, pharmacotherapy, clinical outcomes, and QOL were analyzed using the chi-squared test, independent sample t-test, and binary logistic regression. Results: We screened 3284 inpatients and included consecutive 87 (2.7%) DFS patients. The mean age was 56.08 ± 11.05 years, with a male preponderance (75.8%). Mean HbA1c was 9.9 ± 2.483. About 75% of patients received insulin, and polypharmacy was noticed in 82.7%. About 67.8% of DFS patients had other vascular complications of diabetes, with diabetic retinopathy being the most common in 89%. Amputations were noticed in 32.1% of patients. Overall, poor QOL was seen in 79.3% of patients. The mean scores for different domains were as follows: physical, 41.51 ± 14.15; psychological, 42.90 ± 11.16; social relationships, 43.06 ± 19.36; and environment, 47.17 ± 13. The presence of complications from diabetes was a significant predictor of the utilization of antihypertensives (OR: 2.92, CI [1.09, 7.79], P = 0.03) and poor QOL (OR: 4.54, CI [0.965, 21.41], P = 0.05). Conclusion: DFS patients in this study were found to be younger with poor glycemic control and other vascular complications of diabetes. The presence of other complications of diabetes in DFS patients was found to be a predictor of pharmacotherapy and poor QOL.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Pasangha, E., George, B., Bhuvana, K. B., & Padmini, D. (2022). Predictors of Pharmacotherapy and Quality of Life Among Patients With Diabetic Foot Syndrome: A Cross-Sectional Study from a Tertiary Care Hospital in India. Journal of Pharmacology and Pharmacotherapeutics, 13(1), 66–71. https://doi.org/10.1177/0976500X221080291